Macleod Pharmaceuticals Inc is categorized under Medical Research in Fort Collins, CO and active since 2012.
Macleod Pharmaceuticals Inc was established in 2012, and today employs 1 to 4, earning $10.000.000 to $19.9999.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 4242101 by the NAICS.
If you are seeking more information, feel free to contact Michael Pay, Owner at the company’s single location by writing to 2600 Canton Court # C, Fort Collins, Colorado CO 80525 or by phoning (970) 482-7254. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Macleod Pharmaceuticals Inc |
| Contact Person: | Michael Pay, Owner |
| Address: | 2600 Canton Court # C, Fort Collins, Colorado 80525 |
| Phone Number: | (970) 482-7254 |
| Website Address: | neogen.com |
| Annual Revenue (USD): | $10.000.000 to $19.9999.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 4242101 |
| Share This Business: |
Macleod Pharmaceuticals Inc was started in 2012 to provide professional Medical Research under the SIC code 8733 and NAICS code 4242101. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $10.000.000 to $19.9999.999 per annum.
Feel free to contact Michael Pay, Owner for inquiries that concern Macleod Pharmaceuticals Inc by calling the company number (970) 482-7254, as your correspondence is most welcome. Additionally, the physical location of the single location of Macleod Pharmaceuticals Inc can be found at the coordinates 40.56135,-105.02808 as well as the street address 2600 Canton Court # C in Fort Collins, Colorado 80525.
For its online presence, you may visit Macleod Pharmaceuticals Inc’s website at neogen.com and engage with its social media outlets through on Twitter and on Facebook.